Role of Lipid Signaling by Platelet-Activating Factor Receptor in Tubular Epithelial Cells in Acute Kidney Injury-to-CKD Transition
Journal of the American Society of Nephrology · 2026-11 · 37 (11) · 2390-2406
DOI: 10.1681/asn.0000001132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 27.05.2026. Verfasst von Liangjing Lv und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Kidney Disease of Chongqing, Chongqing Clinical Research Center of K…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Receptors, G-Protein-Coupled, Epithelial Cells, Kidney Tubules. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key program of the Natural Science Foundation of China, Joint Funds of the National Natural Science Foundation of China, National Excellent Youth Fund Program.
Abstract (Originalsprache)
Key Points Platelet-activating factor receptor contributed to renal tubular epithelial cells G2/M arrest through suppressing mouse double minute 2–mediated p53 ubiquitin degradation in AKI-to-CKD transition. Phosphatidylethanolamine (18:0/18:1) served as a novel endogenous ligand of platelet-activating factor receptor, inducing the downstream signaling. WAY-639497, a small-molecule platelet-activating factor receptor antagonist identified by virtual screening, mitigated renal tubular epithelial cells G2/M arrest and AKI-to-CKD transition.
Background
AKI represents a critical clinical complication with a high propensity of progression to CKD, yet effective therapies remain limited. G protein–coupled receptors mediate diverse pathophysiological processes and are promising therapeutic targets. Here, we investigated the role of platelet-activating factor receptor (PTAFR), a lipophilic G protein–coupled receptor, in AKI-to-CKD transition.
Methods
A mouse model of ischemia-reperfusion injury (IRI)–induced AKI was built by bilateral renal artery clamping. The phenotypic role of PTAFR in renal tubular epithelial cells (RTECs) after AKI was investigated in tubule-specific PTAFR-deficiency mice. The functional and molecular mechanisms were determined by transcriptomic profiling, flow cytometry, coimmunoprecipitation, Western blotting, and immunofluorescence. Lipidomic analysis and biological experiments were used to identify the endogenous ligand of PTAFR. The translational potential of PTAFR was evaluated by structure-based high-throughput virtual screening of a small-molecule inhibitor in vivo and in vitro assays.
Results
The expression of PTAFR was upregulated in RTECs after AKI in vivo and in vitro . Tubule-specific depletion of PTAFR alleviated IRI-induced RTEC injury and kidney fibrosis after AKI. Mechanistically, PTAFR promoted RTECs G2/M arrest by suppressing mouse double minute 2–mediated p53 ubiquitin degradation. Phosphatidylethanolamine (18:0/18:1) was identified as a novel PTAFR endogenous ligand inducing RTECs G2/M arrest. Urinary phosphatidylethanolamine (18:0/18:1) was correlated with kidney dysfunction and was able to effectively distinguish patients with AKI from healthy controls. High-throughput virtual screening identified WAY-639497, a small-molecule PTAFR antagonist, that was able to mitigate IRI-induced RTEC injury and kidney fibrosis after AKI.
Conclusions
PTAFR promoted tubular epithelial cell G2/M arrest by inhibiting mouse double minute 2–mediated p53 ubiquitin degradation and further contributed AKI-to-CKD transition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, the Key Laboratory for the Prevention and Treatment of Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University…
ORCID-Profile: Liangjing Lv, Wang Xin, Qigang Lan, Fugang Li, Jiachuan Xiong, Yinghui Huang, Yaqin Wang, Shuiqin Gong, Jinghong Zhao
Förderung
- Key program of the Natural Science Foundation of China
- Joint Funds of the National Natural Science Foundation of China
- National Excellent Youth Fund Program
- National Key R&D Program of China
- Natural Science Foundation of China
- Chongqing Graduate Innovation Program
Zitieren
APA
Lv, L., Xin, W., Lan, Q., Li, F., Xiong, J., Huang, Y., Nie, L., Li, Y., Wang, S., Wang, Y., Yao, M., Gong, S., Xin, Q., Qin, S., & Zhao, J. (2026). Role of Lipid Signaling by Platelet-Activating Factor Receptor in Tubular Epithelial Cells in Acute Kidney Injury-to-CKD Transition. Journal of the American Society of Nephrology, 37(11), 2390-2406. https://doi.org/10.1681/asn.0000001132
Vancouver
Lv L, Xin W, Lan Q, Li F, Xiong J, Huang Y, et al. Role of Lipid Signaling by Platelet-Activating Factor Receptor in Tubular Epithelial Cells in Acute Kidney Injury-to-CKD Transition. Journal of the American Society of Nephrology. 2026;37(11):2390-2406. doi:10.1681/asn.0000001132
BibTeX
@article{Lv2026,
author = {Lv, Liangjing and Xin, Wang and Lan, Qigang and Li, Fugang and Xiong, Jiachuan and Huang, Yinghui and Nie, Ling and Li, Yan and Wang, Shaobo and Wang, Yaqin and Yao, Mengying and Gong, Shuiqin and Xin, Qing and Qin, Shaozong and Zhao, Jinghong},
title = {Role of Lipid Signaling by Platelet-Activating Factor Receptor in Tubular Epithelial Cells in Acute Kidney Injury-to-CKD Transition},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {11},
pages = {2390--2406},
doi = {10.1681/asn.0000001132}
}
EUVIMED